NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/24/2026
Back to search
Official data from USPTO
OXYGEN AMPLIFIED THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OXYGEN AMPLIFIED THERAPY
ST13
US500000097582197Class
3
Filing
97582197
Registration
8152295
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/25/2026
Trademark type
Word
Nice classes
3
Filing date
09/07/2022
Registration date
02/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/24/2026
Last transaction
02/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/05/2022
First use in commerce
11/05/2022
Drawing code
4
Owner type
03
Owner location
Sherman Oaks, CA, US
Examiner
WICKERSHAM, JUSTIN SPENCER
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DermOQ Inc.
DermOQ Inc.
Representatives
Jamie Shelden LAW OFFICE OF JAMIE SHELDEN
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
After sun creams; anti-aging cream; eye cream; eye gels; facial moisturizers; night cream; skin emollients; skin lotion; skin toners; wrinkle removing skin care preparations; after-shave balms; aftershave creams; after-shave lotions; cosmetic skin fresheners; nonmedicated anti-aging serum; skin clarifiers
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/24/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/04/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/04/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/08/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/08/2026
IUAF
USE AMENDMENT FILED
07/03/2025
EISU
TEAS STATEMENT OF USE RECEIVED
07/03/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/06/2025
EX2G
SOU EXTENSION 2 GRANTED
02/06/2025
EXT2
SOU EXTENSION 2 FILED
02/05/2025
EEXT
SOU TEAS EXTENSION RECEIVED
02/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/05/2024
EX1G
SOU EXTENSION 1 GRANTED
08/05/2024
EXT1
SOU EXTENSION 1 FILED
08/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/05/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/10/2023
GNRT
NON-FINAL ACTION E-MAILED
08/10/2023
CNRT
NON-FINAL ACTION WRITTEN
08/10/2023
DOCK
ASSIGNED TO EXAMINER
06/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2022
NWAP
NEW APPLICATION ENTERED
09/10/2022
Continuous trademark protection
Get notified about every new filing that threatens OXYGEN AMPLIFIED THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.